Tim trained as a Pharmacologist with Undergraduate degree from University of Cambridge and DPhil from the University of Oxford before joining the Boston Consulting Group’s London office. Since then Tim has been a biotech investor and company-builder at Syncona, Third Rock Ventures, and Oxford Sciences, gaining experience across therapeutic modalities and geographies. Tim leads Monograph’s investments in Aviado and Ascend.